8h
MedPage Today on MSNClotting Risk Worse Than Expected in Protein S-Deficient PatientsCarriers of these high-risk variants had total protein S levels that were about half of normal. Less severe gene variants ...
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
11h
GlobalData on MSNNovo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic dealNovo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for ...
10h
GlobalData on MSNNovo Holdings and TA Associates back BiocompositesNovo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...
AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...
We recently published an article titled Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate. In this ...
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...
Technology and Consumer Discretionary are the only two sectors down in the first two months of this year, among the 11 market ...
13h
Hosted on MSNIs Trending Stock Novo Nordisk A/S (NVO) a Buy Now?Novo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares ...
After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO) has come down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results